n-benzyladriamycin-14-valerate has been researched along with mitoxantrone in 2 studies
Studies (n-benzyladriamycin-14-valerate) | Trials (n-benzyladriamycin-14-valerate) | Recent Studies (post-2010) (n-benzyladriamycin-14-valerate) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
---|---|---|---|---|---|
25 | 0 | 3 | 4,555 | 1,042 | 1,004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darzynkiewicz, Z; Kapuscinski, J; Traganos, F | 1 |
Ganapathi, R; Grabowski, D; Israel, M; Schmidt, H; Seshadri, R | 1 |
2 other study(ies) available for n-benzyladriamycin-14-valerate and mitoxantrone
Article | Year |
---|---|
Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
Topics: Acridine Orange; Animals; Caffeine; Cell Cycle; Cell Division; Doxorubicin; Drug Interactions; Ellipticines; Flow Cytometry; Mice; Mitoxantrone; Nucleic Acids; Spectrophotometry | 1991 |
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Leukemia, Experimental; Menogaril; Mice; Mitoxantrone; Naphthacenes; Nogalamycin; Trifluoperazine | 1985 |